blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0674174

EP0674174 - Multilayer analytical element for salicylate assay [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.06.2002
Database last updated on 13.11.2024
Most recent event   Tooltip07.06.2002No opposition filed within time limitpublished on 24.07.2002  [2002/30]
Applicant(s)For all designated states
Johnson & Johnson Clinical Diagnostics, Inc.
100 Indigo Creek Drive Rochester
New York 14650 / US
[N/P]
Former [1995/39]For all designated states
Johnson & Johnson Clinical Diagnostics, Inc.
100 Indigo Creek Drive
Rochester New York 14650 / US
Inventor(s)01 / Arter, Thomas C.
217 Andiron Lane
Rochester, New York 14612 / US
02 / Warren, Karen L.
390 Stonybrook Road
Rush, New York 14543 / US
03 / Warren, Harold C.
390 Stonybrook Road
Rush, New York 14543 / US
[1995/39]
Representative(s)Mercer, Christopher Paul
Carpmaels & Ransford LLP
One Southampton Row
London
WC1B 5HA / GB
[N/P]
Former [1995/39]Mercer, Christopher Paul
Carpmaels & Ransford 43, Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date95301991.624.03.1995
[1995/39]
Priority number, dateUS1994021800425.03.1994         Original published format: US 218004
[1995/39]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0674174
Date:27.09.1995
Language:EN
[1995/39]
Type: A3 Search report 
No.:EP0674174
Date:28.02.1996
[1996/09]
Type: B1 Patent specification 
No.:EP0674174
Date:01.08.2001
Language:EN
[2001/31]
Search report(s)(Supplementary) European search report - dispatched on:EP11.01.1996
ClassificationIPC:G01N33/52, C12Q1/26
[1995/39]
CPC:
C12Q1/26 (EP,US); G01N33/526 (EP,US); Y10S435/805 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   FR,   GB,   IT,   LI,   NL,   SE [1995/39]
TitleGerman:Analytisches Vielschichtelement zur Bestimmung von Salicylat[1995/39]
English:Multilayer analytical element for salicylate assay[1995/39]
French:Dispositif d'analyse multicouches pour la détermination de salicylate[1995/39]
Examination procedure02.08.1996Examination requested  [1996/40]
22.11.1999Despatch of a communication from the examining division (Time limit: M04)
28.03.2000Reply to a communication from the examining division
25.08.2000Despatch of communication of intention to grant (Approval: Yes)
28.12.2000Communication of intention to grant the patent
24.01.2001Fee for grant paid
24.01.2001Fee for publishing/printing paid
Opposition(s)03.05.2002No opposition filed within time limit [2002/30]
Fees paidRenewal fee
12.03.1997Renewal fee patent year 03
10.03.1998Renewal fee patent year 04
11.03.1999Renewal fee patent year 05
13.03.2000Renewal fee patent year 06
16.03.2001Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]US4252896  (SHAFFAR MARK R) [A] 1* column A *;
 [Y]WO8300147  (CHARLES HOSPITAL DEV [AU]) [Y] 1-8 * page 1, line 6 - page 2, line 3 *;
 [Y]EP0450714  (EASTMAN KODAK CO [US]) [Y] 1-8 * column W *;
 [D]US5185249  (ARTER THOMAS C [US], et al)
 [A]  - ORR ET AL., "Interaction between valproic acid and aspirin ....", CLINICAL PHARMACOLOGY AND THERAPEUTICS, ST. LOUIS, MO, vol. 31, no. 5, pages 642 - 649 [A] 1 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.